Thermo Fisher Scientific Inc

549.24-1.50-0.27%Vol 1.53M1Y Perf 18.36%
May 20th, 2022 15:34 DELAYED
BID549.09 ASK549.42
Open558.92 Previous Close550.74
Pre-Market554.60 After-Market-
 3.86 0.70%  - -
Target Price
663.79 
Analyst Rating
Strong Buy 1.50
Potential %
21.55 
Finscreener Ranking
★★★     49.66
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★+     49.16
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★★     60.26
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★+     36.70
Price Range Ratio 52W %
47.31 
Earnings Rating
Strong Buy
Market Cap215.01B 
Earnings Date
28th Apr 2022
Alpha0.01 Standard Deviation0.06
Beta0.83 

Today's Price Range

544.44565.92

52W Range

438.72672.34

5 Year PE Ratio Range

27.2058.10

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
1.72%
1 Month
-6.84%
3 Months
2.53%
6 Months
-13.41%
1 Year
18.36%
3 Years
109.48%
5 Years
221.08%
10 Years
1 014.30%

TickerPriceChg.Chg.%
TMO549.24-1.5000-0.27
AAPL135.92-1.4300-1.04
GOOG2 161.91-53.0000-2.39
MSFT248.96-4.1799-1.65
XOM91.400.26000.29
WFC41.28-0.7200-1.71
JNJ175.982.03501.17
FB192.481.19000.62
GE74.73-1.0100-1.33
JPM116.14-2.1688-1.83
Financial StrengthValueIndustryS&P 500US Markets
1.00
1.60
0.43
0.81
16.70
Leverage Ratio 2.10
ProfitabilityValueIndustryS&P 500US Markets
48.40
22.30
29.20
17.20
18.52
RevenueValueIndustryS&P 500US Markets
41.12B
105.05
17.14
15.38
DividendsValueIndustryS&P 500US Markets
0.22
1.20
13.62
12.29
Payout ratio4.00
Earnings HistoryEstimateReportedSurprise %
Q01 20226.177.2517.50
Q04 20215.226.5425.29
Q03 20214.675.7623.34
Q02 20215.515.601.63
Q01 20216.697.217.77
Q04 20206.867.093.35
Q03 20204.375.6328.83
Q02 20202.673.8945.69
Earnings Per EndEstimateRevision %Trend
6/2022 QR4.93-9.71Negative
9/2022 QR4.93-2.57Negative
12/2022 FY22.680.71Positive
12/2023 FY24.501.83Positive
Next Report Date-
Estimated EPS Next Report6.17
Estimates Count8
EPS Growth Next 5 Years %13.00
Volume Overview
Volume1.53M
Shares Outstanding391.46K
Shares Float390.91M
Trades Count45.62K
Dollar Volume848.88M
Avg. Volume1.49M
Avg. Weekly Volume1.39M
Avg. Monthly Volume1.60M
Avg. Quarterly Volume1.48M

Thermo Fisher Scientific Inc (NYSE: TMO) stock closed at 550.74 per share at the end of the most recent trading day (a 1.58% change compared to the prior day closing price) with a volume of 1.98M shares and market capitalization of 215.01B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 75000 people. Thermo Fisher Scientific Inc CEO is Marc N. Casper.

The one-year performance of Thermo Fisher Scientific Inc stock is 18.36%, while year-to-date (YTD) performance is -17.46%. TMO stock has a five-year performance of 221.08%. Its 52-week range is between 438.72 and 672.34, which gives TMO stock a 52-week price range ratio of 47.31%

Thermo Fisher Scientific Inc currently has a PE ratio of 28.20, a price-to-book (PB) ratio of 5.17, a price-to-sale (PS) ratio of 5.13, a price to cashflow ratio of 22.50, a PEG ratio of 2.32, a ROA of 9.81%, a ROC of 12.58% and a ROE of 20.53%. The company’s profit margin is 18.52%, its EBITDA margin is 29.20%, and its revenue ttm is $41.12 Billion , which makes it $105.05 revenue per share.

Of the last four earnings reports from Thermo Fisher Scientific Inc, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $6.17 for the next earnings report. Thermo Fisher Scientific Inc’s next earnings report date is -.

The consensus rating of Wall Street analysts for Thermo Fisher Scientific Inc is Strong Buy (1.5), with a target price of $663.79, which is +21.55% compared to the current price. The earnings rating for Thermo Fisher Scientific Inc stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Thermo Fisher Scientific Inc has a dividend yield of 0.22% with a dividend per share of $1.20 and a payout ratio of 4.00%.

Thermo Fisher Scientific Inc has a Neutral technical analysis rating based on Technical Indicators (ADX : 7.92, ATR14 : 18.94, CCI20 : 45.36, Chaikin Money Flow : -0.10, MACD : -6.27, Money Flow Index : 46.11, ROC : 0.81, RSI : 50.45, STOCH (14,3) : 72.02, STOCH RSI : 0.91, UO : 52.37, Williams %R : -27.98), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Thermo Fisher Scientific Inc in the last 12-months were: Debora L. Spar (Sold 200 shares of value $108 872 ), Jim P. Manzi (Sold 2 072 shares of value $1 152 824 ), Joseph Holmes (Option Excercise at a value of $150 440), Joseph Holmes (Sold 759 shares of value $411 948 ), Marc N. Casper (Option Excercise at a value of $3 893 100), Marc N. Casper (Sold 67 600 shares of value $36 638 688 ), Mark P. Stevenson (Option Excercise at a value of $35 021 908), Mark P. Stevenson (Sold 188 475 shares of value $116 870 117 ), Michel Lagarde (Sold 6 100 shares of value $3 301 890 ), Stephen Williamson (Option Excercise at a value of $2 926 313), Stephen Williamson (Sold 22 550 shares of value $14 389 043 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
10 (76.92 %)
11 (78.57 %)
11 (78.57 %)
Moderate Buy
1 (7.69 %)
1 (7.14 %)
1 (7.14 %)
Hold
1 (7.69 %)
2 (14.29 %)
2 (14.29 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
1 (7.69 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.50
Strong Buy
1.32
Strong Buy
1.32

Thermo Fisher Scientific Inc

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments (revenue figures include some cross-segment revenue): analytical technologies (16% of sales); specialty diagnostic products (17%); life science solutions (38%); and lab products and services (38%).

CEO: Marc N. Casper

Telephone: +1 781 622-1000

Address: 168 Third Avenue, Waltham 02451, MA, US

Number of employees: 75 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

33%67%

Bearish Bullish

66%34%

Bearish Bullish

65%35%

Bearish Bullish

58%42%

TipRanks News for TMO

Fri, 20 May 2022 03:56 GMT Thermo Fisher (TMO) Received its Third Buy in a Row

- TipRanks. All rights reserved.

Fri, 20 May 2022 03:55 GMT Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), Thermo Fisher (TMO) and Atreca (BCEL)

- TipRanks. All rights reserved.

Tue, 10 May 2022 09:02 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: Thermo Fisher (TMO), Galecto (GLTO) and Eledon Pharmaceuticals (ELDN)

- TipRanks. All rights reserved.

Wed, 02 Mar 2022 10:18 GMT Inside Thermo Fishers Newly Added Risk Factors

- TipRanks. All rights reserved.

Sun, 27 Feb 2022 10:39 GMT Thermo Fisher (TMO) Gets a Buy Rating from Credit Suisse

- TipRanks. All rights reserved.

Thu, 24 Feb 2022 17:53 GMT Thermo Fisher Scientific: Strong Growth, Relatively Overvalued

- TipRanks. All rights reserved.

Wed, 09 Feb 2022 16:13 GMT Thermo Fisher Scientific: Strong Q4, Forward EPS Estimates

- TipRanks. All rights reserved.

Sun, 06 Feb 2022 13:42 GMT Thermo Fisher (TMO) Gets a Buy Rating from Robert W. Baird

- TipRanks. All rights reserved.

Sun, 06 Feb 2022 13:42 GMT Thermo Fisher (TMO) Gets a Buy Rating from Leerink Partners

- TipRanks. All rights reserved.

Thu, 27 Jan 2022 17:33 GMT Thermo Fisher Scientific: Recent Correction Proves Compelling

- TipRanks. All rights reserved.

Thu, 06 Jan 2022 14:08 GMT Thermo Fisher (TMO) Receives a Buy from Leerink Partners

- TipRanks. All rights reserved.

News

Stocktwits